Compared to other study populations, the highest prevalence of macrolide resistance genes in CC1 isolates was observed among non-pregnant disease isolates (84 %, 1568/2139; Table S11), most especially ermA (40 %, 864/2139) and ermB (31 %, 672/2139). Here, TMEM94 is linked to glycogen storage disease VI.